We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Synthetic Gene Networks Enable Rapid Virus Detection

By LabMedica International staff writers
Posted on 04 Nov 2014
An original method for using engineered gene circuits has been developed that allows investigators to safely activate the cell-free, paper-based system by simply adding water.

The low-cost, easy-to-use synthetic gene network platform that can control the activity of genes and recognize nucleic acids and small molecules could enable the rapid detection of different strains of deadly viruses such as Ebola.

Scientists at the Wyss Institute for Biological Inspired Engineering (Harvard University, Boston, MA, USA) developed a cell-free, paper-based system suitable for use outside specialized laboratories. More...
To test the clinical relevance of their method, they developed sensors capable of detecting ribonucleic acid (RNA) molecules made from genes that allow bacteria to survive antibiotics, as well as RNA molecules encoding proteins from two different strains of the highly deadly Ebola virus. When freeze-dried onto paper, the sensors quickly detected the presence of these RNA molecules demonstrating the usefulness of the approach for diagnostic purposes.

The scientists created circuits with colorimetric outputs for detection by eye and fabricated a low-cost, electronic optical interface for field use. They tested to see whether the enzyme activity required for transcription and translation could be reconstituted from freeze-dried cell-free expression systems, which normally require storage at -80 °C. A new generation of riboregulators was tested in an in vitro demonstration of toehold switches and these robust biomolecular switches provide tight translational regulation over transcripts and exhibit excellent orthogonality.

James J. Collins, PhD, a professor and senior author of the study, “Our paper-based system could not only improve tools currently only available in the laboratory, but would be readily useful for the field, and also improve the development of new tools. Considering the projected cost, reaction time, ease of use, and no requirement for laboratory infrastructure, we envision paper-based synthetic gene networks significantly expanding the role of synthetic biology in the clinic, global health, and education.” The study was published on October 23, 2014, in the journal Cell.

Related Links:

Wyss Institute for Biological Inspired Engineering




New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Specimen Radiography System
TrueView 200 Pro
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.